ZEB2 and breast carcinoma: Although RAB6C-AS1, ZEB2-AS1, and CBR3-AS1 have high expressions in breast tumor cells, only CBR3-AS1 lncRNA was observed to have a high chance to be a breast cancer biomarker via ROC analysis.